BioNTech (BNTX)
(Delayed Data from NSDQ)
$112.28 USD
-0.23 (-0.20%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $113.13 +0.85 (0.76%) 6:20 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 101 - 120 ( 165 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
FDA Delays Advisory Committee on COMIRNATY in Young Kids; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple COVID-19 Vaccine Updates; Attrition Unwarranted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Fourth Booster Dose Appears to Provide Little Protection; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Booster Emergency Use Authorization Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY E.U. Supply Increase; Omicron Data Update; Modulating PT to $366
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Novel Variant Emerges; COMIRNATY Updates; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Broadened COMIRNATY Booster Approval Likely; Upgrading to Buy and $360 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Projected COMIRNATY Sales Set to Break Records; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
CHMP Recommends Booster Shots; Oncology Pipeline Updates; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Potential COMIRNATY FDA Approval for Children Expected in 4Q21; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
FDA Grants EUA to COMIRNATY Booster in Select Populations; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Full Approval; Booster Rollout Next Month; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COVID-19 Booster Shots Approved; ACIP Meeting Takeaways; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Full FDA Approval and Booster Plan Near-Term; Raising PT to $330
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Cell Therapy Platform and Manufacturing Facility Acquisition; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R